SpecificationsOrganism/cell line/tissue*Mus musculus*/C2C12SexNASequencer or array typeIllumina HiSeq 1500, Illumina Hiseq 2000, Illumina GA IIxData formatRaw data: FASTQ files\
Processed data: BEDGRAPH, TXTExperimental factorsMyoblast vs myotubeExperimental featuresUsing RNA-seq, we identified hundreds of high confidence novel lincRNAs in skeletal muscle. Among these lincRNAs, one near the YY1 transcription factor caused our attention, which we named Linc-YY1. We then used ChIP-seq and RNA-seq to investigate the function of this novel lincRNA during myogenesis.ConsentNASample source locationManassas, VA, USA

1. Direct link to deposited data {#s0005}
================================

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74049>.

2. Experimental design, materials, and methods {#s0010}
==============================================

2.1. Cell culture {#s0015}
-----------------

Mouse C2C12 myoblasts cell line was purchased from American Type Culture Collection (ATCC). The myoblasts were maintain in growth medium (DMEM, 10%FBS and 1% Penicillin/Streptomycin), and induced to myotubes by culturing in differentiation medium (DMEM, 2% horse serum and 1% Penicillin/Streptomycin).

2.2. ChIP assays and sequencing experiments {#s0020}
-------------------------------------------

ChIP assays were performed as previously described [@bb0010], [@bb0015]. About 2 × 10^7^ C2C12 cells and 5 μg of antibodies were used in one immunoprecipitation. The antibodies include YY1 (Santa Cruz Biotechnology), Ezh2 (Active Motif), Eed (Millipore), trimethyl-histone H3-K27 (Millipore), or normal mouse IgG (Santa Cruz Biotechnology) as a negative control.

For library construction, we used a protocol as described before [@bb0020]. Briefly, the immunoprecipitated DNA (\~ 10 ng) were end-repaired, and A-nucleotide overhangs were then added, followed by adapter ligation, PCR enrichment, size selection and purification. The purified DNA library products were evaluated using Bioanalyzer (Agilent) and SYBR qPCR and diluted to 10 nM for sequencing on Illumina Hi-seq 2000 sequencer (YY1) (pair-end with 50 bp) or Illumina Genome Analyzer II sequencer (Ezh2, Eed and H3K27me3) (pair-end with 36 bp). Technical replicates were prepared by sequencing the same library twice. A data analysis pipeline CASAVA 1.8 (Illumina) was employed to perform the initial bioinformatics analysis (base calling). [Table 1](#t0005){ref-type="table"} lists all the experiments that we had performed. For MB YY1, we performed two biological replicates with the antibody SC-1703 and a third biological replicate with a second antibody AB58066. We also performed two technical replicates for each antibody (run 1 and run 2).

2.3. Read alignment and peak calling {#s0025}
------------------------------------

The sequenced reads were mapped to the mouse reference genome (UCSC mm9, non-repeat-masked) using SOAP2 [@bb0025] (v2.20) allowing a maximum of two mismatches and only the uniquely aligned reads were kept. The sequencing and mapping information from each dataset were shown in [Table 1](#t0005){ref-type="table"}. The protein-DNA binding peaks were identified using Model-based Analysis for ChIP-seq (MACS [@bb0030], v1.4.2) with IgG control sample as background. The p-value cutoff was set as 10^− 5^ to call high-confidence binding sites.

2.4. Whole transcriptome sequencing experiments {#s0030}
-----------------------------------------------

Preparation of RNA-seq libraries for sequencing on the Illumina platforms was carried out using the RNA-Seq Sample Preparation Kit (catalog number RS-930-1001) according to the manufacturer\'s standard protocol. Briefly, purified RNA was fragmented *via* incubation for 5 min at 94\'C with the Illumina supplied fragmentation buffer. The first strand of cDNA was next synthesized by reverse transcription using random oligo primers. Second-strand synthesis was conducted by incubation with RNase H and DNA polymerase I. The resulting double-stranded DNA fragments were subsequently end-repaired and A-nucleotide overhangs were added by incubation with Taq Klenow lacking exonuclease activity. After the attachment of anchor sequences, fragments were PCR amplified using Illumina-supplied primers and loaded onto the Hiseq 2000 or GAIIx flow cell. DNA clusters were generated with an Illumina cluster station with Paired-End Cluster Generation Kit v2 (Illumina), followed by 50 (or 26 bp)\*2 cycles of sequencing on sequencer with Sequencing Kit v3 (Illumina). Genome Analyzer Sequencing Control Software (SCS) v2.5, which could perform real-time image analysis and base calling, was used to carry out the image processing and base calling during the chemistry and imaging cycles of a sequencing run. The default parameters within the data analysis software (SCS v2.5) from Illumina were used to filter poor-quality reads. In the default setting, a read would be removed if a chastity of \< 0.6 is observed on two or more bases among the first 25 bases.

2.5. Transcriptome assembly and novel lincRNA identification {#s0035}
------------------------------------------------------------

To generate a comprehensive catalog of lincRNAs in muscle cells, we applied an integrated analysis on RNA-seq data generated by Trapnell et al. [@bb0035] and our own RNA-seq data from proliferating and differentiating C2C12 cells. The raw sequencing reads were aligned to the mouse reference genome (UCSC mm9) using Tophat (v2.0.4) [@bb0035], during which procedure the UCSC gene annotation file downloaded from Cufflinks website (<http://cole-trapnelllab.github.io/cufflinks/igenome_table/index.html>) was used (the '-G' option). The transcriptome assembly was then performed using Cufflinks (v2.0.4) [@bb0035], and a total of 46,627 transcripts were obtained. Then sebnif (v1.2.2) [@bb0040] was employed to identify the high-confidence novel lincRNAs. In this procedure, the annotated genes, transcript size, expression level and coding potential were all considered. As a result, a total of 2413 novel lincRNAs were identified. After further annotating each of them with features including K4-K36 domain, EST tag and MyoD binding, a stringent set of 158 lincRNAs were obtained.

2.6. Differentially expressed genes analysis {#s0040}
--------------------------------------------

To detect the differentially expressed genes between siNC- and siLinc-YY1-transfected C2C12 cells, the raw RNA-seq data were first preprocessed (adapter trimming and duplicate removing using in-house programs) and then aligned to the reference genome (UCSC mm9) using Tophat (version 2.0.4), during which procedure the UCSC gene annotation file downloaded from Cufflinks website (<http://cole-trapnelllab.github.io/cufflinks/igenome_table/index.html>) was used (the '-G' option). The sequencing and mapping information were shown in [Table 1](#t0005){ref-type="table"}. Cuffdiff (version 2.0.4) [@bb0035] was then applied on the aligned data set against the RefSeq gene annotation, to determine differentially expressed genes with a 'significant' status. The GO analysis of the differentially expressed genes was performed using DAVID (<http://david.abcc.ncifcrf.gov/>).

###### 

Sequencing and mapping information for the experiments.

  Type       Sample       Treatment                            Raw reads     Pre-processed[⁎](#tf0005){ref-type="table-fn"}   Mapped reads   Mappability (%)
  ---------- ------------ ------------------------------------ ------------- ------------------------------------------------ -------------- -----------------
  ChIP-seq   Ezh2         Vector transfected                   33,033,076    NA                                               22,480,371     68.1
  ChIP-seq   EED          Vector transfected                   42,772,454    NA                                               32,563,476     76.1
  ChIP-seq   H3K27me3     Vector transfected                   42,897,641    NA                                               33,224,324     77.5
  ChIP-seq   IgG          Vector transfected                   46,757,140    NA                                               35,189,696     75.3
  ChIP-seq   Yy1          Linc-YY1 transfected                 120,778,675   28,875,468                                       22,368,411     77.5
  ChIP-seq   Ezh2         Linc-YY1 transfected                 45,143,782    NA                                               35,378,560     78.4
  ChIP-seq   EED          Linc-YY1 transfected                 45,229,883    NA                                               34,536,361     76.4
  ChIP-seq   H3K27me3     Linc-YY1 transfected                 46,306,903    NA                                               35,814,707     77.3
  ChIP-seq   IgG          Linc-YY1 transfected                 38,713,272    NA                                               27,863,812     72.0
                                                                                                                                             
  RNA-seq    siNC         Negative control oligo transfected   248,983,238   112,409,997                                      94,952,575     84.5
  RNA-seq    siLinc-YY1   siLinc-YY1 oligo transfected         275,819,571   64,514,698                                       52,448,804     81.3

The preprocessing procedure is only performed on samples with high duplication rate designed to remove the duplicated reads while not for others with low duplication rate (shown as 'NA').
